A pivotal moment in the fight to end AIDS -- ensuring lifesaving innovation reaches those who need it most, wherever they live ...

Trump administration funding cuts and dismantling of USAID force the focus to shift from elimination back to treatment.

Lower-income countries, including South Africa, gain unprecedented access to lenacapavir, a revolutionary HIV prevention drug ...

Many HIV-positive sex workers in South Africa relied on private clinics funded by the US government's now-defunct aid agency, ...

HIV jab has signed a deal to supply the costly injection at a knock-down price to as many as two million people in poorer countries.

In an interview with The News & Observer, Dr. Barton Haynes discusses the future of HIV vaccine development after HHS ...

U.S. aid cuts to global AIDS programs spark warnings of millions of deaths, as clinics close and progress unravels in ...

A landmark breakthrough in HIV prevention — a scientific feat decades in the making — received final approval from the Food and Drug Administration last month. Gilead Sciences’ lenacapavir is ...

A new report says the withdrawal of U.S. funding has caused a “systemic shock” to the global effort against AIDS and HIV.